Differential geographical risk of initial pseudomonas aeruginosa acquisition in young US children with cystic fibrosis

American Journal of Epidemiology

Volumn 179, Issue 12, 2014, Pages 1503-1513

  Psoter, Kevin J ^a   Rosenfeld, Margaret ^b,c   De Roos, Anneclaire J ^d   Mayer, Jonathan D ^b,e,f   Wakefield, Jon ^e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

^d DREXEL UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f Allergy and Infectious Diseases   (United States)

Author keywords

Bayesian hierarchical spatial models; cystic fibrosis; interval censoring; intrinsic conditional autoregression; Pseudomonas aeruginosa; Weibull regression

Indexed keywords

BACTERIUM; CHILD HEALTH; HEALTH RISK; HIERARCHICAL SYSTEM; PATHOGENICITY; RESIDENT POPULATION; WEIBULL THEORY;

ARTICLE; CHILD; CLIMATE; CYSTIC FIBROSIS; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PSEUDOMONAS AERUGINOSA; RISK FACTOR; UNITED STATES;

UNITED STATES;

PSEUDOMONAS AERUGINOSA;

BAYESIAN HIERARCHICAL SPATIAL MODELS; CYSTIC FIBROSIS; INTERVAL CENSORING; INTRINSIC CONDITIONAL AUTOREGRESSION; PSEUDOMONAS AERUGINOSA; WEIBULL REGRESSION;

CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; GEOGRAPHY, MEDICAL; HUMANS; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK; SPATIAL ANALYSIS; UNITED STATES;

EID: 84902477603     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu077     Document Type: Article

References (40)

1. Cystic Fibrosis Foundation. Patient Registry 2008 Annual Report. Bethesda, MD: Cystic Fibrosis Foundation; 2009.
2. Dakin CJ, Numa AH, Wang H, et al. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med. 2002;165(7): 904-910.
3. Rosenfeld M, Gibson RL, McNamara S, et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol. 2001;32(5): 356-366.
4. Burns JL, Gibson RL, McNamara S, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001;183(3): 444-452.
5. Li Z, Kosorok MR, Farrell PM, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA. 2005; 293(5): 581-588.
6. Pressler T, Frederiksen B, Skov M, et al. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection - a case control study. J Cyst Fibros. 2006;5(1): 9-15.
7. Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002; 34(2): 91-100.
8. Kerem E, Corey M, Stein R, et al. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients. Pediatr Infect Dis J. 1990;9(7): 494-498.
9. Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001;32(4): 277-287.
10. Pamukcu A, Bush A, Buchdahl R. Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol. 1995;19(1): 10-15.
11. Cystic Fibrosis FoundationBorowitz D, Robinson KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009; 155(6 suppl): S73-S93.
12. Hansen CR, Pressler T, Høiby N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros. 2008;7(6): 523-530.
13. Høiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros. 2005; 4(suppl 2): 49-54.
14. Foght JM, Westlake DW, Johnson WM, et al. Environmental gasoline-utilizing isolates and clinical isolates of Pseudomonas aeruginosa are taxonomically indistinguishable by chemotaxonomic and molecular techniques. Microbiology. 1996;142(Pt 9): 2333-2340.
15. Speert DP, Campbell ME, Henry DA, et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med. 2002;166(7): 988-993.
16. Baussano I, Tardivo I, Bellezza-Fontana R, et al. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa. Pediatrics. 2006;118(3): 888-895.
17. De Braekeleer M, Allard C, Leblanc JP, et al. Genetic determinants of Pseudomonas aeruginosa colonization in cystic fibrosis patients in Canada. Eur J Clin Microbiol Infect Dis. 1998;17(4): 269-271.
18. Green DM, McDougal KE, Blackman SM, et al. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients. Respir Res. 2010;11(1): 140-148.
19. Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol. 1998;26(2): 81-88.
20. Maselli JH, Sontag MK, Norris JM, et al. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol. 2003;35(4): 257-262.
21. Rosenfeld M, Emerson J, McNamara S, et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J Cyst Fibros. 2012;11(5): 446-453.
22. Collaco JM, McGready J, Green DM, et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS One. 2011;6(11):e27784.
23. Psoter KJ, De Roos AJ, Wakefield J, et al. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Clin Microbiol Infect. 2013;19(11): E483-E489.
24. McKone EF, Emerson SS, Edwards KL, et al. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet. 2003;361(9370): 1671-1676.
25. Rowntree RK, Harris A. The phenotypic consequences of CFTR mutations. Ann Hum Genet. 2003;67(Pt 5): 471-485.
26. Martino S, Akerkar R, Rue H. Approximate Bayesian inference for survival models. Scand J Stat. 2011;38(3): 514-528.
27. Kneib T. Mixed model-based inference in geoadditive hazard regression for interval-censored survival times. Comput Stat Data Anal. 2006;51(2): 777-792.
28. Waller LA, Gotway CA. Applied Spatial Statistics for Public Health Data. Hoboken, NJ: John Wiley & Sons; 2004.
29. Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc Series B Stat Methodol. 2009; 71(2): 319-392.
30. Besag J, York J, Mollié A. Bayesian image restoration with two applications in spatial statistics. Ann Inst Statist Math. 1991;43: 1-59.
31. Fong Y, Rue H,Wakefield J. Bayesian inference for generalized linear mixed models. Biostatistics. 2010;11(3): 397-412.
32. Wakefield J. Disease mapping and spatial regression with count data. Biostatistics. 2007;8(2): 158-183.
33. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
34. Rosenfeld M, Emerson J, McNamara S, et al. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort. Pediatr Pulmonol. 2010;45(9): 934-944.
35. Treggiari MM, Rosenfeld M, Mayer-Hamblett N, et al. Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study. Contemp Clin Trials. 2009;30(3): 256-268.
36. Collaco JM, Blackman SM, McGready J, et al. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr. 2010; 157(5): 802-807.e1-3.
37. Green DM, Collaco JM, McDougal KE, et al. Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis. J Pediatr. 2012;161(2): 290-295.e1.
38. Mayer JD. Geography, ecology and emerging infectious diseases. Soc Sci Med. 2000;50(7-8): 937-952.
39. Lunn DJ, Thomas A, Best N, et al. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10(4): 325-337.
40. Software. University of Washington faculty web server. http:// faculty.washington.edu/jonno/software.html. Accessed April 27, 2014.